← Back to headlines
RBC Capital raises price target for Moderna (MRNA)
RBC Capital has increased its price target for Moderna (MRNA), signaling a positive outlook for the pharmaceutical company's stock.
9 Jul, 10:41 — 9 Jul, 10:41
Sources
Showing 1 of 1 sources
